Friday, July 24, 2026

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

How Samsung’s Galaxy S26 Ultra’s Privacy Display Can Protect Your Data in Public

A survey reveals 1 in 4 UK residents admit to peeking at strangers' smartphones, raising privacy concerns and changing phone usage habits.

THE $ECRET TICKET SCAM: Is The U.S. Selling Visa Priority To World Cup Fans In A Shocking Cash Grab?

FIFA and the U.S. introduce FIFA PASS for priority visa interviews for 2026 World Cup ticket holders, easing entry concerns.

Tag: dual inhibitor

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.